Scientists delve into clotting issues associated with J&J vaccine as pause disrupts local distributions

Scientists delve into clotting issues associated with J&J vaccine as pause disrupts local distributions

Andrew Noymer, an epidemiologist and population health [associate professor] at UC Irvine, has that concern as well. “The vaccines are absolutely the best thing going right now,” he said. “These incidents are quite rare — we’re talking about one in a million — and your chance of getting COVID and dying from it is worse than that. This pause is actually a sign of how conservative and careful the FDA and its European equivalent are in terms of tolerance for adverse effects, because even one in a million is enough to pause. “But I am a little worried that this vaccine will never recover in the public’s mind ….”